share_log

4: Statement of changes in beneficial ownership of securities-Director FIELD PAUL

4: Statement of changes in beneficial ownership of securities-Director FIELD PAUL

4:持股變動聲明-董事 FIELD PAUL
美股sec公告 ·  05/21 20:25
Moomoo AI 已提取核心訊息
On May 16, 2024, Paul Field, associated with 60 Degrees Pharmaceuticals, completed a purchase of 4,000 shares of common stock at a transaction price of $0.223 per share. Following this transaction, Field's direct holdings in the company increased to a total of 14,000 shares. The transaction, which is categorized as an exercise or conversion of derivative security, reflects Field's investment activity in the company's stock and is part of the insider trading disclosures required by regulatory authorities.
On May 16, 2024, Paul Field, associated with 60 Degrees Pharmaceuticals, completed a purchase of 4,000 shares of common stock at a transaction price of $0.223 per share. Following this transaction, Field's direct holdings in the company increased to a total of 14,000 shares. The transaction, which is categorized as an exercise or conversion of derivative security, reflects Field's investment activity in the company's stock and is part of the insider trading disclosures required by regulatory authorities.
2024年5月16日,與60度製藥相關的保羅·菲爾德以每股0.223美元的交易價格完成了對4,000股普通股的收購。在這筆交易之後,菲爾德在該公司的直接持股量增加到總計14,000股。該交易被歸類爲衍生證券的行使或轉換,反映了菲爾德對公司股票的投資活動,是監管機構要求的內幕交易披露的一部分。
2024年5月16日,與60度製藥相關的保羅·菲爾德以每股0.223美元的交易價格完成了對4,000股普通股的收購。在這筆交易之後,菲爾德在該公司的直接持股量增加到總計14,000股。該交易被歸類爲衍生證券的行使或轉換,反映了菲爾德對公司股票的投資活動,是監管機構要求的內幕交易披露的一部分。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息